A target action date for the FDA is expected in Q3 2023 and if greenlit, Sanofi’s nirsevimab would be the first broadly-approved RSV vaccine for children.
News
Eversana debuts ‘operating system’ for targeting HCPs, patients
As Medicare Advantage continues to gain popularity among seniors, three Southern California companies are pioneering new types of plans that target cultural and ethnic communities.
News
Rx Rundown: Novartis, Goldman Sachs, Klick Health and more
Maternal deaths keep rising, with Black and Indigenous mothers most at risk, and the number of babies who died before their fir birthday climbed last year.